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The kinase DOUBLETIME is a master regulator of the
Drosophila circadian clock, yet the mechanisms
regulating its activity remain unclear. A proteomic
analysis of DOUBLETIME interactors led to the
identification of an unstudied protein designated
CG17282. RNAi-mediated knockdown of CG17282
produced behavioral arrhythmicity and long periods
and high levels of hypophosphorylated nuclear
PERIOD and phosphorylated DOUBLETIME. Over-
expressionofDOUBLETIME in flies suppresses these
phenotypes and overexpression of CG17282 in S2
cells enhances DOUBLETIME-dependent PERIOD
degradation, indicating that CG17282 stimulates
DOUBLETIME’s circadian function. In photorecep-
tors, CG17282 accumulates rhythmically in PERIOD-
and DOUBLETIME-dependent cytosolic foci. Finally,
structural analyses demonstrated CG17282 is a
noncanonical FK506-binding protein with an inac-
tive peptide prolyl-isomerase domain that binds
DOUBLETIME and tetratricopeptide repeats that
may promote assembly of larger protein complexes.
We have named CG17282 BRIDE OF DOUBLETIME
and established it as a mediator of DOUBLETIME’s
effects on PERIOD, most likely in cytosolic foci that
regulate PERIOD nuclear accumulation.
INTRODUCTION
Circadian clocks, which drive daily cycles of behavior and phys-
iology, are synchronized by cycles of light and temperature but
drive persistent rhythms in the absence of any environmental in-
puts. The mechanism for these self-sustaining biological clocks
has been subjected to genetic analyses in several model sys-
tems, including the fruit fly (Hardin, 2011). While differences exist
across the phylogenetic tree, a general feature of these clocks
is regulation of transcription by proteins whose oscillations
are controlled in part by posttranslational modifications. The
Drosophila circadian clock has been a particularly useful model984 Neuron 80, 984–996, November 20, 2013 ª2013 Elsevier Inc.for the mammalian clock because most of the key circadian
proteins are conserved in flies and mammals (Lowrey and Taka-
hashi, 2011). The Drosophila PERIOD protein (PER) is a key
circadian transcriptional regulator conserved in flies and mam-
mals, and its circadian oscillations have been extensively char-
acterized at both the transcriptional and posttranscriptional
levels. PER does not accumulate during the day because newly
translated PER is phosphorylated by DOUBLETIME (DBT) and
degraded, as is the TIMELESS protein (TIM), which is degraded
in response to light via its interaction with the CRYPTOCHROME
(CRY) photoreceptor. After the lights go out at night, the activity
of DBT is antagonized by accumulating TIM, which also binds
with PER and promotes its nuclear localization. In the nucleus,
PER represses its transcription as well as the transcription of
many other clock-controlled genes responsive to the CLOCK/
CYCLE (CLK/CYC) heterodimer. This repression is ultimately
relieved when DBT targets PER for degradation after the lights
return, thereby allowing another daily accumulation of PER
(Hardin, 2011).
DBT is an ortholog of vertebrate casein kinase Iε and d, which
are likewise involved in the vertebrate circadian clock and target
vertebrate PER orthologs for degradation (Lowrey and Takaha-
shi, 2011). Casein kinase Is (CKIs) are considered messenger-in-
dependent kinases that are not directly regulated by intracellular
signaling, although prior phosphorylation upstream of a CKI
target site can prime phosphorylation at that CKI target site,
thereby linking CKI activity to intracellular signals (Gross and
Anderson, 1998). Likewise, priming of DBT activity by the
NEMO kinase has been documented for its phosphorylation of
PER (Chiu et al., 2011; Yu et al., 2011).
Another potential mode of regulation for DBT may be
conferred by proteins associating with DBT in multiprotein
complexes to target or modulate its activity toward substrates.
Genetic analyses may have missed some of these, because
lack of DBT activity is lethal (Kloss et al., 1998; Price et al.,
1998; Suri et al., 2000; Zilian et al., 1999). In order to identify novel
clock components that interact with DBT, and because recent
proteomic analyses of the mammalian clock have identified
several important components (Brown et al., 2005; Robles
et al., 2010), we undertook a proteomic analysis in Drosophila
S2 cells to identify proteins that interact with DBT. Several pro-
teins were identified in immunoprecipitates of MYC-tagged
DBT, but not in control immunoprecipitates of cells lacking the
Figure 1. CG17282 Associates with DBT
In Vitro and In Vivo
These results are representative of those obtained
in three replicates.
(A) GST pull-down assay. In vitro-translated
CG17282 was incubated with glutathione beads
bound with GST or a wild-type DBT-GST fusion
protein (‘‘dbtWT’’). In the upper panel, Coomassie
staining detects GST proteins on the beads and
ovalbumin (‘‘OVA’’) added to prevent nonspecific
binding. In the lower panel, input or bound
CG17282 (labeled with fluorescent lysine) is
detected by laser scanning.
(B) Coimmunoprecipitation assays of S2 cell
extracts. Untagged DBT or DBT-MYC was ex-
pressed from a pMT plasmid in S2 cells, and the
extracts were immunoprecipitated with an anti-
MYC antibody. CG17282 was detected with
antibodies to CG17282, while DBT-MYC was
detected with an antibody to the C terminus of
DBT and tubulin with an anti-tubulin antibody.
(C) Coimmunoprecipitation of fly head extracts.
DBT-MYC was expressed in transgenic flies (dbt-
myc) with the genotype timGAL4 > UAS-dbt-myc,
while control flies (nontransgenic, or NON-TF)
contained only the timGAL4 driver. DBT-MYCwas
immunoprecipitated with antibodies to MYC from
extracts collected at ZT1 and was detected in
the immunoprecipitate with an antibody against
DBT, while coimmunoprecipitated CG17282 was
detected with antibody to CG17282.
(D) Affinity isolation of CG17282(1–120) using GST-DBT. The N-terminal region of CG17282 with or without the coexpression of DBT-GST was transiently
expressed in HEK293 cells and purified from cell lysates using glutathione beads. The presence of GST-DBT and CG17282 was detected by immunoblotting
using antibodies raised against DBT and CG17282, respectively.
See Table S1 for peptides from CG17282 identified in pull-downs with DBT-MYC and Figure S1 for the assay of PER/BDBT interaction.
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of RACK1, which was also identified by Robles et al. (2010) as
a component of mammalian clock protein complexes. The inves-
tigation of another one of these interactors is presented here.
This protein interacts with DBT in vitro, in S2 cells, and in fly
heads, and it is essential for normal cycles of PER nuclear accu-
mulation and circadian behavior. Genetic analysis in flies and cell
biological analysis in Drosophila S2 cells demonstrate that it
stimulates DBT’s clock functions, including phosphorylation-
dependent degradation of PER. Immunofluorescent analysis
indicates that this DBT-interacting protein accumulates rhythmi-
cally in cytosolic foci at times when PER begins to accumulate in
the nuclei of circadian cells. Furthermore, structural analysis
demonstrates that this interactor is a noncanonical FK506-bind-
ing protein, thus highlighting a hitherto uncharacterized role for
this class of proteins in the circadian clock.
RESULTS
Drosophila Bride of DBT Interacts with DBT
DBT proteins from S2 cells stably transformed with plasmid ex-
pressing MYC-tagged DBT proteins were immunoprecipitated
with an anti-MYC resin, and coimmunoprecipitating proteins
were visualized by SDS-PAGE. One protein immunoprecipitated
with full-length DBTWT or catalytically inactive DBTK/R, but not
with C-terminally truncated forms of DBT, and it was identifiedby mass spectrometry to be CG17282 (Table S1 available
online). CG17282 is a previously unstudied predicted gene in
the Drosophila genome sequence.
Several approaches were employed to confirm the interac-
tion with DBT. Using glutathione S-transferase (GST)-fused
DBT, we are able to pull down in vitro-translated CG17282
(Figure 1A). Moreover, CG17282 was also shown to bind
with DBT-MYC expressed from a transgene in S2 cells by
coimmunoprecipitation (Figure 1B). DBT-MYC expressed in
fly heads with the circadian driver timGAL4 coimmunopreci-
pitated with CG17282 (Figure 1C). Finally, as will be explained
below, we were intrigued by the apparent lack of known func-
tional domains in the N-terminal region of CG17282 and
decided to test whether this region could mediate direct
interaction with DBT. Because S2 cells express low levels of
CG17282 and DBT, which could complicate interpretation of
the binding data, we conducted pull-down experiments in
HEK293 cells and found that DBT bound to the N-terminal
region of CG17282 (Figure 1D).
In order to determine whether CG17282 binds directly to PER,
in vitro-translated PER was incubated with GST-CG17282, and
no interaction with PER was detected by GST pull-down (Fig-
ure S1). Therefore, it is unlikely that CG17282 binds PER directly.
Because it encodes a DBT-binding protein, we have named this
gene bride of dbt (bdbt), with a nod to a previous gene discov-
ered as an interactor (Reinke and Zipursky, 1988)Neuron 80, 984–996, November 20, 2013 ª2013 Elsevier Inc. 985
Table 1. Locomotor Activity Rhythms of Flies with BDBT RNAi
Knockdown
Genotype
Average Period +
SEM
Percent
Rhythmic (n)
elavGAL4 >; +/UAS-dcr2 23.9 hr ± 0.1 96% (28)
UAS-dcr2; timGAL4 > /+ 24.7 hr ± 0.1 97% (31)
UAS-dcr2/40059 24 hr 6% (16)
UAS-dcr2; 100028/+ 23.9 hr ± 0.1 67% (48)
40059/UAS-dcr2; timGAL4 > /+ 0% (12)
elavGAL4 >; 100028/UAS-dcr2 0% (37)
UAS-dcr2; timGAL4 > /100028 30.8 hr ± 0.8 1% (154)
timGAL4 > /+ 24.6 hr ± 0.3 63% (8)
timGAL4 > /100028 25.5 hr ± 0.1a 93% (27)
timGAL4 > /UAS-bdbt-flag 23.6 hr ± 0.1 77% (13)
timGAL4 > /+; UAS-dbtWT/+ 23.8 hr ± 0.2 44% (16)
timGAL4 > /+; UAS-dbtK/R/+ 0% (10)
timGAL4 > /100028;
UAS-bdbt-flag
24.0 hr ± 0.1 77% (13)
timGAL4 > /100028;
UAS-dbtWT-myc/+
23.7 hr + 0.05 69% (16)
timGAL4 > /100028;
UAS-dbtK/R-myc/+
0% (6)b
Flies were entrained for at least 3 days to 12 hr:12 hr LD and then were
placed in constant darkness for activity monitoring. Rhythmic flies pro-
duced clear circadian rhythms by visual inspection of the records and a
single strong peak in periodogram analysis. 100028 (on chromosome II)
and 40059 (on X chromosome) are two different UAS-bdbt RNAi lines
obtained from the Vienna Drosophila RNAi Center. Males were tested,
except for 40059 flies. UAS-dcr2 was an X chromosome insertion for
timGAL4 (on chromosome II) progeny and a II chromosome insertion
for elavGAL4 (on the X chromosome) progeny. See Table S2 and Fig-
ure S2 for locomotor activity rhythms in flies expressing BDBT-FLAG in
a wild type background or DBTK/R-MYC in a bdbt RNAi background.
UAS-bdbt-flag line 12F1A was used to rescue the arrhythmicity of the
bdbt RNAi phenotype. The dbtWT and dbtK/R lines, which suppress and
enhance the bdbt RNAi phenotype, have been described previously
(Muskus et al., 2007). Note the long-period phenotype of bdbt
RNAi flies without dcr2. The average periodogram amplitudes for
timGAL4 > /100028, timGAL4 > /100028; UAS-bdbt-flag, and
timGAL4 > /100028; UAS-dbtWT-myc/+ rhythmic flies are 87%, 100%,
and 78% of the average for control progeny without a timGAL4 driver.
n, the total number of flies tested.
aDiffered significantly from all other genotypes without UAS-dcr2 in
the analysis by Tukey HSD, with p < 0.003. A one-way ANOVA of all
the rhythmic flies without UAS-dcr2 (the bottom half of the table)
indicated a significant effect of genotype on circadian period (F5,62 = 4,
p < 0.0001).
bTen of 16 flies died during the locomotor assay.
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for Circadian Rhythms of Behavior
We employed several genetic approaches to assess whether
Bride of DBT (BDBT) has a role in the mechanism of circadian
rhythms. Overexpression of the FLAG-tagged BDBT in clock
cells of flies (timGAL4 >UAS-bdbt-flag) did not produce an effect
on their locomotor activity rhythms or PER/DBT expression
(Table S2; Figures S2, S3A, and S3B). However, overexpression
of DBT in circadian tissues produces only a slight lengthening of986 Neuron 80, 984–996, November 20, 2013 ª2013 Elsevier Inc.the circadian period (Fan et al., 2009; Muskus et al., 2007; Sekine
et al., 2008; Xu et al., 2005), demonstrating that manipulations
increasing DBT activity over wild-type levels do not necessarily
affect period. Because there are nomutations in the endogenous
gene to allow assessment of loss-of-function phenotypes, we
used RNAi knockdown of the endogenous transcript to investi-
gate bdbt function. Wild-type flies maintained in constant dark-
ness exhibit persistent circadian rhythms of activity, with high
levels of activity during the daylight hours in a previous light/
dark regimen and low levels of activity during the dark hours in
the previous light/dark cycle. However, flies with the genotype
timGAL4 > UAS-dcr2; UAS-bdbt RNAi or elavGAL4 > UAS-
dcr2; UAS-bdbt RNAi exhibited arrhythmic locomotor activity
if allowed to age for 7 days before initiation of the assay (Table 1;
Figure 2A).
In a timGAL4 > UAS-bdbt RNAi genotype without a UAS-dcr2
gene, we obtained a weaker but more clearly circadian pheno-
type exhibiting long periods instead of arrhythmicity (Figure 2B;
Table 1). Finally, light:dark cycles (LD) drove diurnally cycling
behavior that lacked anticipation of the dark-to-light and light-
to-dark transitions in timGAL4 > UAS-dcr2; UAS-bdbt RNAi flies
(Figure 2C); cycles of behavior which lack anticipation of the
lighting transitions are typical of circadian loss-of-function
mutants. Interestingly, the evening peak of activity was largely
missing (Figure 2C), and this also speaks to altered circadian
function. The bdbt RNAi behavioral phenotypes, which include
long period and arrhythmic activity in DD and lack of anticipation
to lighting transitions in LD, establish bdbt as a true circadian
gene.
The parameters for RNAi knockdown were investigated. If
assayed immediately after eclosion from pupae, timGAL4 >
UAS-dcr2; UAS-bdbt RNAi flies were mostly rhythmic with
wild-type periods (data not shown), suggesting that expression
of the RNAi from the timGAL4 driver does not reach high enough
levels to become effective until the adult stage. The results were
obtained with both of the RNAi lines obtained from the VDRC
(Table 1). The efficacy of the knockdown, shown by immunoblot
(Figure 3A, bottom panel), demonstrated partial knockdown of
BDBT protein levels; incomplete knockdown with the circadian
driver is expected if BDBT is expressed in noncircadian tissues.
Consistent with expression in noncircadian neurons, knockdown
with the general neuronal driver elav-GAL4 is more complete
(Figure S4C).
BDBT Contributes to Phosphorylation-Mediated
Degradation of PER and to Posttranslational Regulation
of DBT
Consistent with the locomotor activity arrhythmicity, there were
effects on PER and DBT expression. High levels of PER with
fast mobility on SDS-PAGE, shown in a previous study to arise
from hypophosphorylated PER (Edery et al., 1994), persisted
throughout the day with a dampened oscillation of PER levels
in timGAL4 > UAS-dcr2; UAS-bdbt RNAi flies (Figure 3A, middle
panel). By contrast, PER expression in wild-type flies (‘‘WT’’) var-
iedmore strongly, with the highest levels expressed at ZT19 (7 hr
after the lights go out) and highly phosphorylated (slow-mobility)
forms of PER found from ZT1-7 (1 to 7 hr after the lights come on)
(Edery et al., 1994). Because high levels of phosphorylation
Figure 2. BDBT Is Required in Circadian
Cells to Produce Rhythmic Behavior in DD
and Evening Activity in LD, and the bdbt
RNAi Phenotype Can Be Rescued with
BDBT Overexpression and Suppressed
with DBT Overexpression
(A) Representative DD actogram records of prog-
eny with the indicated genotypes are presented on
the left and the periodogram analyses on the right.
While UAS-dcr2; timGAL4 > /+ flies are mostly
rhythmic with normal periods, knockdown of bdbt
with the circadian timGAL4 driver and UAS-dcr2
eliminates circadian behavior. Lights were on in
the previous LD cycle from ZT0-12 (lighter rect-
angles) and off from ZT12-24 (darker rectangles).
(B) Knockdown without UAS-dcr2 produces long
periods rather than arrhythmia in timGAL4 > bdbt
RNAi flies. Expression of BDBT-FLAG or DBTWT-
MYC in bdbt RNAi flies produces wild-type
locomotor activity rhythms, while expression of
DBTK/R-MYC expression in bdbt RNAi flies (Fig-
ure S2) produces arrhythmia and lethality (10 of 16
flies died during the assay). Summaries of the DD
circadian behavior for different genotypes are
presented in Table 1.
(C) These panels are averaged activity plots from
multiple flies of the wild-type (Canton S) and UAS-
dcr2; timGAL4 > /bdbt RNAi genotypes under an
LD cycle. Lights were on from ZT0-12 (open
rectangle) and off from ZT12-24 (dark rectangles),
and the evening peak is largely missing in the
knockdown genotype, with anticipation of the
lighting transitions missing for both morning and
evening peaks. VDRC line 100028 was used for all
bdbt RNAi records shown.
See Figure S3 for the molecular rhythms with
BDBT-FLAG overexpression in a wild-type back-
ground and as a rescue in bdbt RNAi flies.
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et al., 2002; Muskus et al., 2007; Price et al., 1998), the persistent
levels of PER (particularly at ZT7) in the bdbt RNAi knockdown
are likely the consequence of its reduced phosphorylation.
Intriguingly, there was also an effect on DBT electrophoretic
mobility, as a slowmobility formofDBTwaspresent in timGAL4>Neuron 80, 984–996, NUAS-dcr2; UAS-bdbt RNAi flies (Fig-
ure 3A, top panel). In S2 cells, slow-
mobility forms of DBT are produced by
autophosphorylation of DBT (Fan et al.,
2009; J.-Y.F., unpublished data), sug-
gesting that the interaction of BDBT and
DBT is necessary to maintain DBT in an
unphosphorylated state or to degrade
phosphorylated DBT. In order to assess
the possibility that BDBT knockdown
enhances the accumulation of phosphor-
ylated DBT, extracts from wild-type and
timGAL4 > UAS-dcr2; UAS- bdbt RNAi
flies were treated with lambda phospha-
tase. The electrophoretic mobility of the
slow-mobility DBT isoform found in thebdbt RNAi knockdown flies was converted to a faster-migrating
one, comparable to the mobility of DBT in wild-type controls,
which did not exhibit a mobility shift with phosphatase treatment
(Figure 3B). The phosphatase-dependent shift was partially
antagonized by inhibitors of phosphatase. Hence, bdbt RNAi
knockdown enhances the accumulation of phosphorylatedovember 20, 2013 ª2013 Elsevier Inc. 987
Figure 3. BDBT Is Required for Normal Posttranslational Modifica-
tions of PER, and DBT Phosphorylation Is Increased with bdbt
RNAi Knockdown
(A) Fly heads were collected at the indicated time points in a light:dark cycle
(with lights on from ZT0-12 and off from ZT12-24) and analyzed with immu-
noblots for the indicated antigens. ‘‘WT’’ flies were UAS-dcr2; timGAL4 > /+;
TM3/+ control flies, while bdbt RNAi flies were UAS-dcr2; timGAL4 > /UAS-
bdbt RNAi (from VDRC line 100028). RNAi knockdown of BDBT produced a
form of DBT with retarded electrophoretic mobility due to phosphorylation of
DBT (‘‘p-DBT’’; see B), reduced levels of hyperphosphorylated PER (‘‘hyper-
PER’’), and elevated levels of hypophosphorylated PER. Levels of BDBT
protein were lower in the knockdown flies than in controls. These results are
representative of those obtained in three replicates. See Figure S4 for
assessment of bdbt phenotype with other drivers and responders.
(B) Head extracts were prepared from wild-type (‘‘WT’’) flies and UAS-dcr2;
timGAL4 > /bdbt RNAi flies at ZT7 and treated (+) or not treated () with
lambda phosphatase or treated with lambda phosphatase in the presence of
phosphatase inhibitor (i). Then, the extracts were subjected to immunoblot
analysis for detection of DBT and tubulin. Phosphatase treatment converts the
slow-mobility form of DBT to a form with the same mobility as that found in
wild-type flies, although heterogeneity remains, and the inhibitor antagonizes
the conversion.
(C) The levels of DBT and tubulin were assessed in immunoblot analyses of
four experiments with scans of the chemifluorescent signals. In each experi-
ment, the DBT signal (sum of all bands, both phosphorylated and un-
phosphorylated) for each sample was normalized to the tubulin signal for each
Neuron
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988 Neuron 80, 984–996, November 20, 2013 ª2013 Elsevier Inc.DBT and may produce other posttranslational effects on DBT as
well, because phosphatase treatment did not convert DBT to a
form with homogeneous mobility as in wild-type flies (Figure 3B).
Reduced activity of DBT toward PER, potentially resulting from
autophosphorylation of DBT (as in mammalian CKId/ε; Gross
and Anderson, 1998), may produce the hypophosphorylation
and high levels of PER. Any reduction in activity as a conse-
quence of increased DBT phosphorylation would not be
compensated by increased expression of DBT, as quantification
of multiple blots, with DBT signal normalized to that of tubulin,
indicated equivalent levels of DBT expression in wild-type and
timGAL4 > UAS-dcr2; UAS-bdbt RNAi flies (Figure 3C). As for
the locomotor activity phenotypes, these molecular correlates
on PER and DBT were produced by both RNAi lines and took
from 4 to 7 days after eclosion to become manifest (Figures
S4A and S4B).
The persistent and relatively underphosphorylated levels of
PER in timGAL4 > UAS-dcr2; UAS-bdbt RNAi flies suggest
that BDBT normally acts to enhance the DBT-dependent
phosphorylation and degradation of PER. This was tested by
coexpression of BDBT with PER and/or DBT in S2 cells. Overex-
pression of BDBT enhanced PER degradation in a well-estab-
lished assay for DBT-dependent PER degradation (Ko et al.,
2002; Muskus et al., 2007) (Figure 4B), consistent with an
enhancement of DBT’s effects on PER by BDBT. Intriguingly,
when coexpressed with DBT or PER alone, BDBT also reduced
the levels of DBT or PER (Figure 4A). The effect on PER may be
mediated by BDBT’s effect on DBT, which is expressed endog-
enously in S2 cells and may show enhanced targeting of trans-
genic PER in the presence of BDBT. The relevance of the effect
on DBT for the circadian mechanism is not clear, as DBT levels
do not exhibit circadian oscillations (Kloss et al., 2001; Bao
et al., 2001) and are not higher in timGAL4 > UAS-dcr2; UAS-
bdbt RNAi flies than in controls (Figure 3C). Nevertheless, the
enhanced effect of DBT on PER in S2 cells in the presence of
higher BDBT levels is all the more compelling because it occurs
in the presence of lower levels of DBT (i.e., lower levels of DBT
with BDBT coexpression are more effective at targeting PER
than higher levels of DBT without BDBT coexpression).
The bdbt RNAi Behavioral and Molecular Phenotypes
Are Rescued by Overexpression of Wild-Type BDBT and
Suppressed by Overexpression of Wild-Type DBT
In order to determine whether the bdbt RNAi knockdown pheno-
types were a consequence of specific effects on bdbt RNA and
to assess the relevance of DBT to the phenotype, circadian
behavior and PER oscillations were assayed in bdbt RNAi geno-
types into which a UAS-bdbt-flag or UAS-dbt-myc transgene
had also been introduced (a rescue or genetic interaction exper-
iment, respectively). In timGAL4 > UAS-bdbtRNA-RNAi; UAS-
bdbt-flag flies, behavior was rhythmic in constant darknesssample, and these values were further normalized to the DBT/tubulin signal on
the same blot for wild-type flies collected at ZT1, which thereforewas assigned
a value of ‘‘1.’’ The averages of the normalized protein levels (±SEM) are
plotted here as a function of ZT and genotype. A one-way ANOVA revealed no
statistically significant effect of group on normalized protein amount (F7,24 =
0.863, p = 0.55).
Figure 4. BDBT Reduces DBT and PER Expression in Drosophila S2
Cells
(A) pMT-dbt-myc and/or pAC-per-ha was transiently transfected into
Drosophila S2 cells with or without pAC-bdbt-flag as indicated, and DBT-MYC
was induced with CuSO4. b-tubulin was detected with anti-b-tubulin, while
transgenic DBT and BDBT were detected with antibodies to their epitope tags
on immunoblots and PER with an anti-PER antibody. NS, a nonspecific band.
BDBT leads to lower levels of PER and DBT.
(B) pAC-per-HA, pMT-dbt-myc, and pAC-bdbt-flag were transiently trans-
fected into Drosophila S2 cells as indicated, and different levels of DBT-MYC
were induced. BDBT-FLAG, PER, and b-tubulin were detected as above, while
DBT was detected with anti-DBTC, which detects both endogenous DBT
(migrating between DBT-MYC and BDBT) and DBT-MYC. BDBT enhances the
targeting of PER for degradation by DBT.
(C) bdbt RNAi knockdown in S2 cells. dsRNAi for bdbt was produced from a
PCR fragment for bdbt by in vitro transcription, and the dsRNAi (+) or buffer ()
was added to S2 cells. After 24 hr, cell extracts were analyzed on immuno-
blots. DBT levels increase while BDBT levels decrease in the cells treated with
dsRNAi. These results are representative of those obtained in three replicates.
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and Figure 2B), the PER electrophoretic mobility shift at ZT1
was restored and the amount of DBT with slow electrophoretic
mobility was reduced (Figure S3C), demonstrating a BDBT-spe-
cific rescue of the mutant phenotype. In addition, overexpres-
sion of DBTWT-MYC suppressed the bdbt RNAi phenotype
(Figure 2B), while overexpression of a catalytically inactive
DBTK/R-MYCdid not and in fact enhanced themutant phenotype
by contributing to shortened lifespan (10 of 16 flies died during
the assay; Figure S2C; Table 1). The rescue experiment (along
with the other biochemical and cell biology experimentsdescribed herein) establish the specific involvement of BDBT in
the circadian phenotypes, while the bdbt RNAi knockdown
molecular phenotype (PER hypophosphorylation), the suppres-
sion of the bdbt RNAi phenotype by wild-type DBT overexpres-
sion, and the enhancement of DBT-dependent PER degradation
by BDBT in S2 cells all strongly support the conclusion that
BDBT enhances DBT’s circadian kinase activity.
BDBT Inhibits PERNuclear Accumulation during the Day
in the Neurons that Produce Circadian Rhythms of
Behavior
The circadian oscillation of PER in the lateral neurons of the
brain (Helfrich-Fo¨rster, 1995; Zerr et al., 1990), which are suffi-
cient for circadian locomotor activity rhythms in DD (Frisch
et al., 1994), was affected by bdbt RNAi knockdown. In wild-
type flies, high levels of nuclear PER were detected only at
ZT1 and not at ZT13 in these neurons, whose cytosol is marked
by expression of the neuropeptide PDF (Figures 5A, 5C, and 5D ).
High levels of PER were detected in nuclei of the LNv and in
the LNd at all times of day in timGAL4 > UAS-dcr2; UAS-bdbt
RNAi flies (Figures 5B–5D). While the rhythms of PER are largely
blunted in the timGAL4 > UAS-dcr2; bdbt RNAi flies, the levels
of nuclear PER in the LNs are somewhat elevated at ZT7, sug-
gesting a weak long-period rhythm that did not reach statistical
significance as the wild-type rhythm did (Figures 5C and 5D).
Knockdown of BDBT in timGAL4 > UAS-dcr2, UAS-bdbt RNAi
flies did not eliminate the circadian oscillation of PER subcellular
localization in photoreceptor cells of the eye (first demonstrated
in wild-type flies by Siwicki et al., 1988) (Table S3), most likely
because the knockdown of BDBT is less complete in the
eye than in the LNs (we still detect substantial BDBT protein in
the eye in the timGAL4 > UAS-dcr2; UAS-bdbt RNAi flies; data
not shown).
The Transcription of bdbt Is Independent of the
Transcription of slimb, which Encodes a Part of the
PER-Degradation Machinery
The E3 ubiquitin ligase component SLIMB is essential for
degradation of PER, and slimb mutants produce elevated
levels of PER (Grima et al., 2002; Ko et al., 2002). Because it
is adjacent to bdbt in the Drosophila melanogaster genome, it
was important to determine if bdbt might in fact be a part of
the same transcription unit as slimb. For a number of reasons,
this possibility can be excluded. First, inspection of other fly ge-
nomes in Flybase demonstrates that orthologous genes to bdbt
are not found adjacent to slimb in distantly related Drosophila
species (e.g., Drosophila virilis). Moreover, an antibody to the
N-terminal part of BDBT detected a protein of correct molecu-
lar weight (MW) on western blots (MW 33 kDa; Figure 3A, lower
panel), and the levels of this protein were decreased by RNAi-
mediated knockdown (Figures 3A and S4C) and increased (with
a mobility shift as a consequence of the FLAG tag) in timGAL4 >
UAS-bdbt-flag flies (Figures S3A–S3C). These results show that
BDBT is not a domain within a larger SLIMB protein (59–
69 kDa). Previous work has shown that knockdown of SLIMB
produces a different phenotype, with high levels of PER in a
heterogeneous phosphorylation state (Grima et al., 2002).
Therefore, bdbt encodes a distinct transcription unit fromNeuron 80, 984–996, November 20, 2013 ª2013 Elsevier Inc. 989
Figure 5. BDBT Functions to Reduce Nuclear PER during the Late Day and Early Evening
Whole brains were collected at ZT1, ZT7, ZT13, or ZT19, and PER and PDF were detected by laser scanning confocal microscopy.
(A) PER detected in wild-type flies at ZT1 and ZT13.
(B) UAS-dcr2; timGAL4 > /UAS-bdbt RNAi fly brains. Small and large ventral lateral neurons (s-LNv and l-LNv) colabel with PDF.
(C) The localization of PER in the sLNv (cytosol detected with anti-PDF) was scored blind to the identity of the sample for 8–45 neurons in each group. The relative
percentages of sLNv showing exclusively nuclear PER, exclusively cytoplasmic or undetectable PER, or both nuclear and cytoplasmic PER are shown. A Kruskal-
Wallis nonparamentric ANOVA followed bymultiple comparisons of mean ranks for all groups showed that the wild-type ZT13 group differed significantly from all
other groups (H [5, n = 161] = 120, *p < 0.02 for all pairwise comparisons of wild-type ZT13).
(D) For the LNd, presence or absence of PER signal in the LNd region (adjacent to the LNvs) was scored blind to sample identity for multiple brain hemispheres
(5–18 per group) and the average number of LNds detected was scored. A one-way ANOVA indicated a statistically significant effect of group on the number of
LNd detected (F5,63 = 12, p < 0.001); *wild-type ZT13 flies were different from all other groups except UAS-dcr2; timGAL4 > /bdbt RNAi at ZT19 by Tukey HSD (p <
0.002). Knockdown of BDBT produces elevated nuclear PER in the sLNv and high levels in the LNd at all times of day, while in wild-type flies PER oscillates, with
predominantly cytoplasmic localization or undetectable PER in the sLNv and LNd (respectively) at ZT13. WT, wild-type controls not containing the responder.
See Table S3 for PER oscillations in photoreceptors of UAS-dcr2; timGAL4 > /UAS-bdbt RNAi flies.
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dcr2; UAS-bdbt RNAi flies do not arise from loss of SLIMB
expression. Overall levels of BDBT protein (Figure 3) or of its
mRNA (Figure S3D) did not oscillate in the heads of wild-type
flies. Taken together, these observations indicate that BDBT
is a factor contributing to the circadian oscillations of PER
in vivo by enhancing the DBT-dependent phosphorylation and
degradation of PER.
BDBT Localizes to Cytosolic Foci in Photoreceptor Cells
in a Manner Requiring PER and DBT, and This
LocalizationOccurswhenPER Is Accumulating inNuclei
An antibody to the first 238 amino acids of BDBT was produced
to analyze the distribution of BDBT in photoreceptor cells, which990 Neuron 80, 984–996, November 20, 2013 ª2013 Elsevier Inc.are the principal source of PER expression in fly heads. Strik-
ingly, BDBT is found in cytosolic foci in these cells and there
was a dramatic change in the abundance and subcellular local-
ization of these foci during the course of the day in wild-type flies
(Figure 6). During the day (ZT1 and ZT7), detection was limited to
the outer part of the retina and was not observed in all photore-
ceptors. In early night (ZT13), the foci became more numerous
and broadly localized in the retina, and by ZT19 most photore-
ceptors expressed high levels of the foci in both the inner and
outer parts of the retina. In pero or timGAL4 > UAS-dcr2; UAS-
dbt RNAi fly eyes, the abundance of the foci remained relatively
low and was restricted to the outer layers of the retina at all times
of day, demonstrating that PER and DBT are necessary for the
diurnal changes in BDBT foci. It is noteworthy that BDBT levels
Figure 6. BDBT Forms Cytosolic Foci in
Photoreceptors during the Night in a PER-
and DBT-Dependent Manner
Fly heads were collected at ZT1, ZT7, ZT13, and
ZT19, and cryosections were prepared for immu-
nofluorescent detection of PER and BDBT.
(A) Representative confocal z stack of wild-type
Canton S (WT), pero and UAS-dcr2; timGAL4 > /+;
UAS-dbt RNAi/+ photoreceptors at ZT7 show low
or absent levels of nuclear PER in wild-type and
pero flies and BDBT foci undetectable or restricted
to the outer layers of only a fraction of the
photoreceptors in all genotypes. UAS-dcr2;
timGAL4 > /+; UAS-dbt RNAi/+ flies have high
levels of nuclear PER because of the reduced DBT
activity. White bars indicate the scale (20 mm). In
the representative confocal z stacks of photore-
ceptors at ZT19, when wild-type flies and UAS-
dcr2; timGAL4 > /+; UAS-dbt RNAi/+ exhibit
high levels of nuclear PER, many wild-type flies
exhibit cytosolic BDBT foci ubiquitously through-
out the photoreceptor layer while UAS-dcr2;
timGAL4 > /+; UAS-dbt RNAi/+ and pero flies
continue to exhibit the more restricted pattern of
BDBT foci.
(B) The indicated number of immunofluorescent
images were acquired by one person blind to the
sample identity and scored for the restricted
pattern or ubiquitous pattern of expression by
another person also blind to the identity of the
sample in the image (a double-blind experiment).
The frequency of the ubiquitous pattern is plotted
here. Each type of sample (genotype and time
point) was scored in three to nine experiments,
and in all experiments the wild-type ZT19 group
exhibited higher frequencies of ubiquitous foci
than the wild-type ZT1 or ZT7 groups, or than pero
or timGAL4 > UAS-dcr2; UAS-dbt RNAi groups, at
any time. Data from all experiments were pooled
for the plot shown here, and a Kruskal-Wallis
nonparametric ANOVA followed by multiple
comparisons of mean ranks for all groups showed
that the wild-type ZT19 group differed significantly
from all other groups except the wild-type ZT13
(H [11, n = 860] = 249.7, *p < 0.01 for all pairwise
comparisons of wild-type ZT19, except the one
with wild-type ZT13).
See Figure S5 for an analysis of BDBT levels in the
heads of the genotypes analyzed here.
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heads of pero and timGAL4 >UAS-dcr2;UAS-dbtRNAi flies (Fig-
ure S5), suggesting that the changes in foci over the course of the
day and in the mutant genotypes are not the result of changes in
BDBT levels. Moreover, the lack of foci at ZT1 and ZT7, when
BDBT levels are as high as those at ZT13 and ZT19, suggests
that the BDBT foci are not an inherent feature of BDBT immuno-
fluorescent detection; instead, they are likely to reflect a circa-
dian-clock-dependent change in subcellular localization forNeuron 80, 984–996, NBDBT. A caveat is that the relatively con-
stant levels of BDBT expression detected
by immunoblot may derive mostly from
other sites within the brain, since immu-noreactivity is detected in the brain as well as the eyes and
does not oscillate in the brain (not shown).
Structural Analyses of BDBT Reveal that It Is Related to
FK506-Binding Proteins with Tetratricopeptide Repeats
but Lacks the Residues that Confer FK506-Binding and
Catalytic Activity
Searches of the databases to identify known functional domains
within the BDBT sequence did not pinpoint any known modules,ovember 20, 2013 ª2013 Elsevier Inc. 991
Figure 7. Structural Analysis of BDBT Demonstrates Homology to FK506-Binding Proteins with TPR Domains
(A) Ribbon diagram of the BDBT(1–211). The PPIase-like domain (amino acids 1–120) and the TPR domain (amino acids 121–211) are colored cyan andmagenta,
respectively. Elements of secondary structure are indicated by a (a helices) and b (b strands). The letters N and C indicate the N and C termini, respectively.
(B) Overlay of the structures of FKBP1A (white) and the FKBP domain of BDBT (cyan). Loop regions between strand b4 and helix a1 and between strands b5 to b6
where most of the catalytic residues are found in FKBP1A are colored red and indicated using black arrows. Please note that the structures of these loops are
dramatically altered in BDBT. Movie S1 depicts a 360 view of this overlay.
(C) Structure-based alignment of BDBT with FKBP1A shows conservation of secondary structural elements and some residues, but not the residues that bind
FK506 or rapamycin. Strictly conserved residues are shaded in black and similar residues are colored gray. The letters a and b indicate the positions of a helices
and b strands, respectively. Residues highlighted in red in the FKBP1A sequence are found in the overlapping FK506/rapamycin-binding sites and the isomerase
catalytic site. This alignment was constructed using DaliLite (Holm et al., 2008).
(D) Overlay of the structures of amino acids 139–330 of FKBP51 (white) and BDBT(1–211) (cyan/magenta).
(legend continued on next page)
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FK506-Binding Protein: A Circadian Clock Componentsave for a homology to tetratricopeptide repeats (TPRs) in the
C-terminal part of BDBT. A single TPR comprises 34 amino
acids forming a helix-turn-helix motif, and search algorithms
identified three such structural elements in the C-terminal part
of the protein. Domains composed of TPR motifs often mediate
protein-protein interactions (Zeytuni and Zarivach, 2012), so that
the inclusion of such structural elements in BDBT, while suggest-
ing a role in mediating protein-protein interaction, was not espe-
cially informative.
To shed light into the function of BDBT in the Drosophila circa-
dian clock, we determined two crystal structures: one of its
N-terminal region (amino acids 1–120) that includes the DBT-
binding site (Figure 1D) and one of the first 211 amino acids.
The structure of BDBT(1–120) was solved by multiwavelength
anomalous diffraction using L-selenomethionine-labeled protein
and refined to 1.9 A˚ limiting resolution (Rcryst/Rfree = 26.1%/
28.0%; Table S4; Figure S6). This structure was then used as a
model to determine the crystal structure of BDBT(1-211) using
molecular replacement; the final model was refined to 2.5 A˚
(Rcryst/Rfree = 19.7%/22.8%, Table S4). Overall, BDBT(1–211) in-
cludes two distinct domains (Figure 7A). Its N terminus (amino
acids 1–120) is structurally homologous to the peptidyl prolyl
isomerase (PPIase) regions of FK506-binding proteins (FKBPs),
despite low sequence homology (Kang et al., 2008). The closest
structural homolog of the PPIase domain was identified through
DALI as the prototypical immunophilin FKBP1A. These two mol-
ecules superimposewith a root-mean-square deviation (rmsd) of
3.6 A˚ over 74 residues, though they share only 16% sequence
identity (Figures 7B and 7C). Compared to FKBP1A, the N termi-
nus of BDBT includes an additional strand (b1) and the differ-
ences between BDBT and FKBP1A reside primarily in the loops
linking strands b3 and b4, strand b4 to helix a1, and strands b5 to
b6 (Figure 7B; Movie S1). These regions include amino acid res-
idues that make up the FK506 and rapamycin-binding sites,
which overlap with the site of the isomerase activity. Overall,
only 2 of the 13 residues involved in drug-binding or catalytic ac-
tivity (Ikura and Ito, 2007) are conserved in BDBT (Figure 7C), and
the extended loop between strands b3 and b4 occludes the
potential binding pocket (Figure 7B). Taken together with our af-
finity isolation assays (Figure 1D), these observations suggest
that the function of the PPIase domain in BDBT is not to catalyze
the cis/trans-isomerization of proline residues, but rather to
mediate binding to DBT. The C-terminal region of BDBT (amino
acids 121–211) is entirely a-helical and includes one TPR
composed of helices a2 and a3 (Figure 7A). A DALI search iden-
tified FKBP51 as the closest homolog for BDBT(1–211). In spite
of their 18% amino acid sequence identity, the two molecules
superimposewith an rmsdof 3.65 A˚ over 171 residues (Figure 7D)
(Sinars et al., 2003). FKBP51 is an immunophilin thought to be
involved in steroid hormone receptor activity and includes a
catalytically active PPIase domain followed by a catalytically
deficient PPIase domain and a TPR domain. Overall, our work in-(E) Sequence alignment of the TPR region of BDBT with the TPR and HSP90 bind
refers to FKBP51. The secondary structures of FKBP51 and BDBT derived from t
respectively. Strictly conserved residues are shaded in black and similar residues
(Wu et al., 2004).
SeeTableS4 for data collection and refinement statistics andFigureS6 for a summdicates that BDBT is structurally related to the immunophilin
FKBP51 and that it shares a common domain organization con-
sisting of PPIase-like and TPR domains with noncanonical
immunophilins such as FKBP38 or FKBPL (Jascur et al., 2005;
Kang et al., 2008). These structural insights will help guide future
investigations into the mechanistic aspects of BDBT function.
DISCUSSION
While FKBPs were originally identified asmediators of the immu-
nosuppressive effects of FK506 on calcineurin (Liu et al., 1991)
and rapamycin on the Target of Rapamycin (TOR) (Heitman
et al., 1991), subsequent work has suggested their involvement
in a wide range of signaling processes, including ones involved
in neurodegeneration and cancer. In many cases, their function
derives from their catalysis of cis-trans conversions of peptide
bonds involving prolines (Kang et al., 2008). However, BDBT
lacks the necessary catalytic residues, as do several other non-
canonical FKBPs. One of these noncanonical FKBPs (FKBP38)
has been proposed to interact with TOR to suppress its activity,
while interactions between FKBP38 and the small GTP-binding
protein RHEB relieve this repression and activate TOR (Bai
et al., 2007). Intriguingly, TOR and RHEB have recently been
show to modulate the circadian clock of Drosophila (Zheng
and Sehgal, 2010).
However, FKBP proteins have also been implicated in regula-
tion of nuclear localization and protein stability. For instance, the
noncanonical FKBP-like protein (FKBPL) has been implicated in
the nuclear import of steroid hormone receptors in complexes
with HSP90 proteins (Robson and James, 2012). An interesting
possibility is that BDBT is involved in regulating the import of
PER/DBT complexes to the nucleus, and that at least some of
this regulation is negative, as PER exhibits increased nuclear
accumulation in BDBT knockdown flies (Figure 5). This hypothe-
sis is consistent with our structural work, which uncovered a
resemblance between BDBT and the HSP90-binding protein
FKBP51. The HSP90-binding site in FKBP51 localizes to its
TPR domain and all but one of the residues that account for
HSP90 binding are conserved in BDBT in spite of the low
sequence homology with BDBT (Figure 7E) (Wu et al., 2004).
Since the N-terminal, PPIase-like domain of BDBT binds to
DBT in HEK293 cells (Figure 1D), it is possible that BDBT assem-
bles a DBT/PER/HSP90 complex, with DBT bound to the
PPIase-like domain, HSP90 to the TPR domain, and PER bound
to DBT.
FKBPs have also been implicated in the regulation of the sta-
bilities of proteins with which they form a complex (Kang et al.,
2008). A role in enhancement of PER’s phosphorylation-depen-
dent proteolysis is particularly attractive for BDBT, as it would
explain the RNAi knockdown phenotype in head extracts
(elevated levels of hypophosphorylated PER; Figure 3) and the
enhancement of DBT-dependent degradation of PER in S2 cellsing regions of human FKBP51, FKBP52, and FKBPL. The numbering on the top
heir crystal structures are indicated above and below the sequence alignment,
are colored gray. Amino acids that bind to HSP90 in FKBP51 are colored red
ary of the structure determination procedure forBDBT(1–120) andBDBT(1–211).
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accumulate at a time (ZT13-19; Figure 6) when PER transitions
from a destabilized cytosolic form to a stabilized nuclear form,
and our data supporting the involvement of BDBT in enhance-
ment of PER proteolysis suggest that BDBT may be a negative
regulator of this transition (i.e., BDBT antagonizes PER accumu-
lation and nuclear localization). The BDBT foci are intriguing in
light of the finding by Young and coworkers of PER/TIM cytosolic
foci, which form prior to accumulation of PER and TIM in S2 cell
nuclei (Meyer et al., 2006). It was proposed that processes in
these foci trigger the nuclear accumulation of both PER and
TIM. Since the suggestion from our work is that BDBT foci antag-
onize nuclear accumulation of PER and we do not observe
obvious PER foci that colocalize with the BDBT foci (Figure 6),
it is possible that BDBT antagonizes focal accumulation of
PER or immediately triggers the degradation of PER in these
foci. In this scenario, in contrast to the situation in S2 cells,
PER might only accumulate in foci in vivo when BDBT is not pre-
sent or active in the foci, and PER’s presence in foci in vivo may
therefore be difficult to detect because it rapidly accumulates
and localizes to nuclei when BDBT is not active in the foci. It is
also possible that focal accumulation of BDBT negatively regu-
lates BDBT activity toward DBT, since highest levels of BDBT
foci are detected at ZT19, when PER is rapidly accumulating in
nuclei (Figure 6) and therefore any BDBT inhibition of PER nu-
clear accumulation might be inhibited.
Because the mammalian orthologs of DBT (CKIε and CKId) are
also essential for the molecular mechanism of the mammalian
circadian clock (Fan et al., 2009; Lee et al., 2001, 2009; Lowrey
et al., 2000; Xu et al., 2005), it is possible that the mechanism
in which bdbt participates is conserved in mammals. While this
manuscript was in preparation, FKBP and FKBP-like proteins
were reported to form complexes with mammalian CKId and
CKIε (Kategaya et al., 2012), although neither these proteins
nor any other protein in the mammalian genome is an ortholog
of BDBT. We were initially surprised by the lack of homology be-
tween the PPIase-like region in BDBT, whichmediates binding to
DBT (Figure 1D), and the ones found in vertebrates. However,
our binding experiments indicate that the BDBT binding site in
DBT spans its well-conserved N-terminal kinase domain and
the poorly conserved C-terminal tail (not shown). Thus, it seems
likely that the binding modes between BDBT and DBT on one
hand and the ones between the vertebrate homologs of BDBT
and CKId and CKIε differ substantially. While it is not known if
this interaction has any role in the mammalian circadian clock,
these results offer the tantalizing prospect that this class of pro-
teins and their roles are conserved in the mechanisms of the
mammalian and Drosophila clocks.EXPERIMENTAL PROCEDURES
Mass Spectrometry
DBT protein from S2 cells stably transformed with plasmid expressing MYC-
tagged wild-type DBT (DBTWT), a catalytically inactive mutant DBT (DBTK/R;
Muskus et al., 2007) or DBT proteins truncated at various amino acids in the
C-terminal domain, which is dispensable for catalytic activity (amino acids
387, 332, and 296) (Fan et al., 2009), were immunoprecipitated with an anti-
MYC resin, and coimmunoprecipitating proteins were visualized by SDS-
PAGE. One protein immunoprecipitated with full-length DBTWT or DBTK/R,994 Neuron 80, 984–996, November 20, 2013 ª2013 Elsevier Inc.but not with C-terminally truncated forms of DBT. Excised Coomassie-stained
gel bandswere reduced and alkylated and subjected to in-gel trypsin digestion
by standardmethods, and extracted peptides were analyzed by capillary liquid
chromatography-tandem mass spectrometry using a 50 mM i.d. 3 8-cm-long
capillary column packedwith Phenomenex Jupiter C18 reversed-phasematrix
resolvedwith a linear gradient of acetonitrile as described previously (Keightley
et al., 2004). Protein identifications were made using Mascot 2.0 (Matrix
Science) searching against MSDB compiled database release Jan 3, 2004
(1,319,480 sequences), withmanual validation. All peptides used for identifica-
tion and shown in Table S1 received ions scores exceeding threshold for 95%
confidence (Perkins et al., 1999). Peptides fromCG17282were also detected in
two other experiments involving immunoprecipitation of DBT-MYC.
RNAi Fly Stocks and Locomotor Activity Assays
UAS-cg17282 RNAi and UAS-dbt RNAi stocks were obtained from the Vienna
Drosophila RNAi Center and the GAL4 driver lines from the Bloomington Stock
Center. These lines, the genetic crosses employing them, and the activity as-
says are described in greater detail in Supplemental Experimental Procedures
in Supplemental Information. UAS-dbt-myc lines have been previously
described (Muskus et al., 2007).
Generation of BDBT Expression Clones and Transgenic Flies
A cDNA clone for cg17282 (RE50353) was obtained from theDrosophilaGeno-
mics Resource Center (DGRC). In order to clone it into vectors allowing
expression in Drosophila S2 cells or flies, the DGRC Gateway collection was
employed. BDBT was cloned into pGateway vector pAWF (cat 1112) or
pTWF (cat 1116), thereby generating a C-terminal 33 FLAG-tag and allowing
constitutive expression from the Act5C promoter in S2 cells or flies (with a
GAL4 driver), respectively. Transformants were produced by Genetic Ser-
vices. More complete descriptions are given in Supplemental Experimental
Procedures.
Transfection of Drosophila S2 Cells
S2 cells were transiently transfected with pAC-bdbt-flag, pMT-dbt-myc, and/
or pAC-per-ha by cellfectin II (Life Technologies) treatment as previously
described (Muskus et al., 2007) or were treated with double-stranded RNAi
(dsRNAi) for BDBT. To make the dsRNAi, a PCR product was amplified from
BDBT clone RE50353 with Bull’s eye Taq polymerase (Midwest Scientific)
and primers that introduced T7 promoters on each end of the product (forward
primer: 50-GTAATACGACTCACTATAGGG-30; reverse primer: 50-TTAATAC
GACTCACTATAGGGAGAACTAAACATACGTTGCACCA). Then, T7 RNA poly-
merase (Megascript RNAi kit, cat AM1626; Life Technologies) was used to
produce dsRNAi, and this was applied to S2 cells according to the procedure
of the Perrimon lab (http://www.flyrnai.org/DRSC-PRR.html).
BDBT/DBT Interaction Assays
These included GST pull-down assays and immunoprecipitations from
Drosophila S2 cells, fly heads, and human embryonic kidney cells, as
described in Supplemental Experimental Procedures.
Immunodetection of DBT, PER, and BDBT
Antibodies to BDBT were generated to the first 120 or to the first 238 amino
acids of BDBT expressed in E. coli and purified as described in Supplemental
Experimental Procedures. The antibodies were generated in guinea pig by
Covance Research Products.
For immunoblot assays, crude extracts or immunoprecipitates were sub-
jected to SDS-PAGE, transferred to nitrocellulose, and antigens detected
with the appropriate antibodies as described in Supplemental Experimental
Procedures. Extracts were analyzed on either 5.7% (for PER) or 10% (for
DBT, tubulin, actin, and BDBT) SDS-PAGE gels with the ECL procedure (GE
Healthcare) (Muskus et al., 2007). Typically, immunoblots of independent
experiments were performed three times for each figure (see figure legends).
For analysis of DBT modification in bdbt RNAi flies, head extracts were pre-
pared at ZT7 by sonication in 13 phosphatase buffer (7 ml per head in 1.13
buffer from New England Biolabs) and centrifugation at 10,000 rpm for
10 min in a microfuge, and the supernatant was aliquotted into 6 ml aliquots
for treatment with 1 ml of lambda phosphatase (400 U) in 20 ml for 2 hr at
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date and 50 mM NaFl). Then, 53 SDS loading buffer was added, the samples
were treated for 5 min at 100C, and half the sample was loaded on an SDS
10% polyacrylamide gel for immunoblot analysis as described above.
For immunodetection in whole adult brains, brains were dissected from flies
at ZT1, ZT7, ZT13, or ZT19; fixed, permeabilized, and incubated with rabbit
anti-PER and mouse anti-PDF; and followed by incubation with fluorescently
labeled secondary antibodies (anti-rabbit immunoglobulin G [IgG] Alexa Fluor
488 and anti-mouse IgG Alexa Fluor 568, respectively) and imaging on an
Olympus Fluoview confocal. For detection of PER or BDBT in the eyes, sec-
tions prepared with a cryostat were processed for immunocytochemical
detection of PER and DIC imaging or for fluorescent detection of PER
(detected with rabbit anti-PER and anti-rabbit IgG Alexa Fluor 568) and
BDBT (detected with guinea pig anti-BDBT[1–238] and anti-guinea pig IgG
Alexa Fluor 488). Images were scored as described in the figure legends.
More details are given in Supplemental Experimental Procedures.
Quantitative RT-PCR Analysis
A totalof 90–100flyheadswerecollectedandquick-frozen in liquidnitrogen,and
total RNAs were then extracted with an RNA isolation kit (QIAGEN). After quan-
tification of the total RNA, each sample was treated with DNase I for 15 min at
room temperature and analyzed for rp49, per, and bdbt levels by quantitative
real-time RT-PCR, as described in Supplemental Experimental Procedures.
Protein Purification and Crystal Structure Determination
See Supplemental Experimental Procedures for descriptions of protein
expression, purification, and crystal structure determination.
ACCESSION NUMBERS
Coordinates and structure factors for BDBT(1–120) and BDBT(1–211) have
been deposited in the Protein Data Bank with accession numbers 4IT6 and
4IT4, respectively.
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